| D28 | Interventions to enhance uptake of PrEP for high-risk populations in Nampula Province, Mozambique | E-poster | Integration of prevention interventions with care/treatment |
| D100 | Interruption of HIV treatment and prevention services among key populations during the COVID-19 pandemic in Malaysia | E-poster | Combination HIV prevention |
| C48 | Interim feasibility results of a pre-exposure prophylaxis (PrEP) delivery demonstration project among male sex workers in Malindi, Kenya | E-poster | Adherence to HIV prevention strategies |
| D20 | Interactive voice response system (ARTmitra) - a lifeline to prevent treatment interruption during COVID-19 in Mumbai, India | E-poster | Adaptations of HIV treatment services during COVID-19 |
| C34 | Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: an opportunity to achieve dual elimination of HIV and viral hepatitis by 2030 | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| D9 | Integrating Pre-exposure Prophylaxis Delivery in Decentralized Community HIV-testing sites in rural KwaZulu Natal, South Africa | On-demand oral abstract session | Feasibility and acceptability of emerging HIV prevention strategies |
| B32 | Integrase strand transfer inhibitor (INSTI) use and cancer incidence | E-poster | ART in first- and second-line therapies |
| B8 | Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in Africa | E-poster | Drug resistance testing |
| C16 | Initial results of recent HIV infection surveillance in Cambodia, 2020 | Oral abstract session with live Q&A | Novel methods/algorithms for detecting acute and recent HIV infections |
| C27 | Initial implementation of PrEP in Zambian correctional facilities demonstrates high uptake among incarcerated people | E-poster | PrEP |